Cell Signaling Technology

Phospho-PKC Antibody Sampler Kit

#9921 · $793

64
Evidence Score · Well-Established
Used by 191 independent labs across 202 papers. How we score this →
100
Citing papers
7.4k
Combined citations
Supplier page Find this product

Research areas

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis14Immune Response and Inflammation12Neonatal Respiratory Health Research8Pulmonary Hypertension Research and Treatments7Chronic Obstructive Pulmonary Disease (COPD) Research7Neutrophil, Myeloperoxidase and Oxidative Mechanisms5Asthma and respiratory diseases5Barrier Structure and Function Studies4

Papers citing this product

1
Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala
Proceedings of the National Academy of Sciences·2006·498 cit.·DOI
2
Chronic electronic cigarette exposure in mice induces features of COPD in a nicotine-dependent manner
Thorax·2016·342 cit.·DOI
3
Lipid nanoparticle-mediated efficient delivery of CRISPR/Cas9 for tumor therapy
NPG Asia Materials·2017·210 cit.·DOI
4
Oxidative stress dependent microRNA-34a activation via PI3Kα reduces the expression of sirtuin-1 and sirtuin-6 in epithelial cells
Scientific Reports·2016·171 cit.·DOI
5
BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGFβ responses and altered cell mechanics
PLoS Biology·2019·145 cit.·DOI
6
Azithromycin and Roxithromycin define a new family of “senolytic” drugs that target senescent human fibroblasts
Aging·2018·134 cit.·DOI
7
Plectin isoform 1b mediates mitochondrion–intermediate filament network linkage and controls organelle shape
The Journal of Cell Biology·2008·125 cit.·DOI
8
Emodin Inhibition of Influenza A Virus Replication and Influenza Viral Pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB Pathways
Molecules·2017·123 cit.·DOI
9
Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway
PLoS ONE·2017·115 cit.·DOI
10
<p>Paclitaxel alleviated sepsis-induced acute lung injury by activating MUC1 and suppressing TLR-4/NF-κB pathway</p>
Drug Design Development and Therapy·2019·115 cit.·DOI

Similar products

ProductVendorEvidencePricePapers
Phospho-(Ser) PKC Substrate AntibodyRabbitCell Signaling Technology64$430100
Phospho-(Ser) PKC Substrate AntibodyrabbitCell Signaling Technology64——

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.

Your email is never shown publicly.